🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Health Catalyst, Inc.

HCAT Healthcare
$1.31 +$0.02 (1.55%)
Market Cap: $99.76 M
Gurus Holding
3
Popularity Rank
#3039
% of Shares Held
0.27%
Net Activity (Q3 2026)
-$894,280.17

Guru Ownership Trend

Guru Analysis for Health Catalyst, Inc. (HCAT)

Health Catalyst, Inc. (HCAT), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q3 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $273,693.06.

Top institutional holders include Cliff Asness and Renaissance Technologies (RenTech).

Institutional sentiment is currently Slightly Bearish. This is evidenced by a $894,280.17 net outflow during the quarter.

Recent activity highlights Steven Cohen who opened a new position. Conversely, Renaissance Technologies (RenTech) reduced exposure by 77.2%.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q3 2026)

+$34,477
Total Buy Value
New Buys 1
Additions 0
-$928,757.17
Total Sell Value
Reductions 2
Sold Out 0

Guru Consensus (Q3 2026)

Based on recent activity
Net Sellers
2
Net Buyers
1

FAQs for Health Catalyst, Inc. (HCAT)

Major holders include Cliff Asness ($189,256), Renaissance Technologies (RenTech) ($137,708), Steven Cohen ($34,477). According to the latest reported data, 3 tracked investment managers collectively hold approximately 208,926 shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $894,280.17, with 1 managers increasing positions and 2 managers reducing holdings.

During the most recent reporting period, 2 managers trimmed their positions, while 0 fully exited HCAT. The total reported sell value was $928,757.17.

Yes, 1 managers opened new positions in HCAT, and 0 increased their existing holdings. The total reported buy value was $34,477.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.00% Reduce -71.0% 109,397 $189,256 Q3 2026
0.00% Reduce -77.2% 79,600 $137,708 Q3 2026
0.00% New Buy 19,929 $34,477 Q3 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form